| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5623756 | Alzheimer's & Dementia | 2017 | 11 Pages | 
Abstract
												The long gap between NFT accumulation and neuronal loss suggests that a second trigger may be necessary to induce neuronal death in AD. Imaging studies should determine whether LC volumetry can replicate the stage-wise atrophy observed here and how these changes are specific to AD. LC volumetry may develop into a screening biomarker for selecting high-yield candidates to undergo expensive and less accessible positron emission tomography scans and to monitor AD progression from presymptomatic stages.
											Keywords
												
											Related Topics
												
													Life Sciences
													Neuroscience
													Neurology
												
											Authors
												Panos Theofilas, Alexander J. Ehrenberg, Sara Dunlop, Ana T. Di Lorenzo Alho, Austin Nguy, Renata Elaine Paraizo Leite, Roberta Diehl Rodriguez, Maria B. Mejia, Claudia K. Suemoto, Renata Eloah De Lucena Ferretti-Rebustini, Livia Polichiso, 
											